We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 278 results
  1. Steps to Improve Precision Medicine in Epilepsy

    Precision medicine is an old concept, but it is not widely applied across human health conditions as yet. Numerous attempts have been made to apply...

    S. Balestrini, D. Mei, ... Renzo Guerrini in Molecular Diagnosis & Therapy
    Article Open access 27 September 2023
  2. Precision Therapy for Epilepsy Related to Brain Malformations

    Malformations of cortical development (MCDs) represent a range of neurodevelopmental disorders that are collectively common causes of developmental...

    Alissa M. D’Gama, Annapurna Poduri in Neurotherapeutics
    Article 01 July 2021
  3. Restless leg syndrome prevalence in epilepsy patients and its impact on quality of sleep

    This study aimed to determine the frequency of restless leg syndrome (RLS) and other sleep-related movement disorders and their effects on sleep...

    Oya Öztürk, Vasfiye Kabeloğlu, Dilek Ataklı in Sleep and Biological Rhythms
    Article 24 March 2022
  4. Novel Therapeutics for Neonatal Seizures

    Neonatal seizures are a common neurologic emergency for which therapies have not significantly changed in decades. Improvements in diagnosis and...

    Julie M. Ziobro, Krista Eschbach, Renée A. Shellhaas in Neurotherapeutics
    Article 01 July 2021
  5. Anticonvulsant Effectiveness and Neurotoxicity Profile of 4-butyl-5-[(4-chloro-2-methylphenoxy)methyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (TPL-16) in Mice

    Protective (antiseizure) effects of 4-butyl-5-[(4-chloro-2-methylphenoxy)-methyl]-2,4-dihydro-3 H -1,2,4-triazole-3-thione (TPL-16) and acute...

    Magdalena Drabik, Mariusz Głuszak, ... Jarogniew J. Łuszczki in Neurochemical Research
    Article Open access 18 November 2020
  6. Genotype–phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder

    Contactin-associated protein-like 2 ( CNTNAP2 ) gene encodes for CASPR2, a presynaptic type 1 transmembrane protein, involved in cell–cell adhesion and...

    Gianluca D’Onofrio, Andrea Accogli, ... Vanja Nagy in Human Genetics
    Article Open access 14 May 2023
  7. Chemical toxicity by sex differences: a literature review of 2019–2023 studies

    Objective and methods

    While differences in cancer incidence between the two sexes/genders are often explained by differences in environmental exposure...

    Article 26 June 2024
  8. A Method to Induce Lamotrigine-Resistant Corneal Kindled Mice

    The historical identification of promising investigational therapies for the treatment of epilepsy can be credited to the use of several animal...
    Protocol 2021
  9. Identification of abnormal closed-loop pathways in patients with MRI-negative pharmacoresistant epilepsy

    Epilepsy is a disorder of brain networks, that is usually combined with cognitive and emotional impairment. However, most of the current research on...

    **xin Bu, Nanxiao Ren, ... Haitao Zhu in Brain Imaging and Behavior
    Article 09 April 2024
  10. Resting state EEG microstate profiling and a machine-learning based classifier model in epilepsy

    Electroencephalography-based (EEG) microstate analysis is a promising and widely studied method in which spontaneous cerebral activity is segmented...

    Asha SA, Sudalaimani C, ... Ramshekhar N Menon in Cognitive Neurodynamics
    Article 23 March 2024
  11. Exploring the benefits, harms and costs of genomic newborn screening for rare diseases

    Emma L. Baple, Richard H. Scott, ... Zornitza Stark in Nature Medicine
    Article 19 June 2024
  12. Nanoceuticals as Theranostics Against Neurodegenerative Diseases

    Nanoceuticals, also referred to as nutraceuticals, are pharmacological molecules or natural supplements fabricated employing nanotechnology-related...
    Prabhakar Mishra, Santosh Anand in Role of Nutrients in Neurological Disorders
    Chapter 2022
  13. Synergistic Herb-Drug Interactions in Neurological Disorders

    The incidence of neurological disorders of the brain, spine, and nervous system including Alzheimer’s disease (AD), stroke, dementia, epilepsy, and...
    Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble in Herb-Drug Combinations
    Chapter 2022
  14. Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study

    Rett syndrome is a rare, genetic neurodevelopmental disorder. Trofinetide is a synthetic analog of glycine–proline–glutamate, the N-terminal...

    Jeffrey L. Neul, Alan K. Percy, ... James M. Youakim in Nature Medicine
    Article Open access 08 June 2023
  15. Brain Infectious Diseases and Nanotherapy

    Indubitably brain is a highly complex organ and has the responsibility to regulate all the cognitive, behavioral, and emotional activities. The...
    Maharudra Pratap Singh, Santosh Kumar Yadav, ... Syed Shadab Raza in Nanotechnology for Infectious Diseases
    Chapter 2022
  16. Chronic Caffeine Consumption, Alone or Combined with Agomelatine or Quetiapine, Reduces the Maximum EEG Peak, As Linked to Cortical Neurodegeneration, Ovarian Estrogen Receptor Alpha, and Melatonin Receptor 2

    Rationale

    Evidence of the effects of chronic caffeine (CAFF)-containing beverages, alone or in combination with agomelatine (AGO) or quetiapine...

    Sherine Abdelmissih, Sara Adel Hosny, ... Nancy F. Samir in Psychopharmacology
    Article Open access 06 June 2024
  17. Novel compound heterozygous mutation and phenotype in the tetratricopeptide repeat-like domain of the GEMIN5 gene in two Chinese families

    Background

    GEMIN5 is an RNA-binding protein that regulates multiple molecular functions, including splicing, localisation, translation, and mRNA...

    **n Zhang, Yanzhao Guo, ... Zhefeng Yuan in Journal of Human Genetics
    Article 21 July 2023
Did you find what you were looking for? Share feedback.